BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 17267290)

  • 61. Saliva and serum levetiracetam concentrations in patients with epilepsy.
    Mecarelli O; Li Voti P; Pro S; Romolo FS; Rotolo M; Pulitano P; Accornero N; Vanacore N
    Ther Drug Monit; 2007 Jun; 29(3):313-8. PubMed ID: 17529888
    [TBL] [Abstract][Full Text] [Related]  

  • 62. New anti-epileptic drugs for the 21st century.
    McCabe PH
    Expert Opin Pharmacother; 2000 May; 1(4):633-74. PubMed ID: 11249508
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Rash from antiepileptic drugs: influence by gender, age, and learning disability.
    Alvestad S; Lydersen S; Brodtkorb E
    Epilepsia; 2007 Jul; 48(7):1360-5. PubMed ID: 17484761
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Tolerability and efficacy of oral loading of levetiracetam.
    Koubeissi MZ; Amina S; Pita I; Bergey GK; Werz MA
    Neurology; 2008 May; 70(22 Pt 2):2166-70. PubMed ID: 18505995
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Suicidal ideation in epilepsy and levetiracetam therapy.
    Mula M; Sander JW
    Epilepsy Behav; 2007 Aug; 11(1):130-2. PubMed ID: 17544331
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A new look at the second-generation antiepileptic drugs: a decade of experience.
    LaRoche SM
    Neurologist; 2007 May; 13(3):133-9. PubMed ID: 17495757
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Positive and negative psychotropic effects of levetiracetam.
    Helmstaedter C; Fritz NE; Kockelmann E; Kosanetzky N; Elger CE
    Epilepsy Behav; 2008 Oct; 13(3):535-41. PubMed ID: 18583196
    [TBL] [Abstract][Full Text] [Related]  

  • 68. An audit of lamotrigine, levetiracetam and topiramate usage for epilepsy in a district general hospital.
    Chappell B; Crawford P
    Seizure; 2005 Sep; 14(6):422-8. PubMed ID: 16087359
    [TBL] [Abstract][Full Text] [Related]  

  • 69. New antiepileptic drugs in childhood.
    Verrotti A; Trotta D; Morgese G; Chiarelli F
    Panminerva Med; 2002 Sep; 44(3):221-5. PubMed ID: 12094136
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Evidence-based treatment of idiopathic generalized epilepsies with new antiepileptic drugs.
    Bergey GK
    Epilepsia; 2005; 46 Suppl 9():161-8. PubMed ID: 16302891
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The prognostic value of long-term ambulatory electroencephalography in antiepileptic drug reduction in adults with learning disability and epilepsy in long-term remission.
    Koepp MJ; Farrell F; Collins J; Smith S
    Epilepsy Behav; 2008 Oct; 13(3):474-7. PubMed ID: 18602025
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The new antiepileptic drugs and women: efficacy, reproductive health, pregnancy, and fetal outcome.
    Morrell MJ
    Epilepsia; 1996; 37 Suppl 6():S34-44. PubMed ID: 8941040
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The impact of levetiracetam on challenging behavior.
    Hurtado B; Koepp MJ; Sander JW; Thompson PJ
    Epilepsy Behav; 2006 May; 8(3):588-92. PubMed ID: 16473557
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Newer antiepileptic drugs].
    Matsuura M
    Brain Nerve; 2007 Feb; 59(2):147-56. PubMed ID: 17380779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Weight change associated with antiepileptic drugs.
    Pickrell WO; Lacey AS; Thomas RH; Smith PE; Rees MI
    J Neurol Neurosurg Psychiatry; 2013 Jul; 84(7):796-9. PubMed ID: 23236017
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Intravenous levetiracetam for epileptic seizure emergencies in older people.
    Beyenburg S; Reuber M; Maraite N
    Gerontology; 2009; 55(1):27-31. PubMed ID: 18953167
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Quantifying the response to antiepileptic drugs: effect of past treatment history.
    Schiller Y; Najjar Y
    Neurology; 2008 Jan; 70(1):54-65. PubMed ID: 18166707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. An overview of the efficacy and tolerability of new antiepileptic drugs.
    Chadwick DW
    Epilepsia; 1997; 38 Suppl 1():S59-62. PubMed ID: 9092963
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Experimental basis for the treatment of drug-resistant epilepsy].
    Błaszczyk B; Trojnar M; Czuczwar SJ
    Przegl Lek; 2006; 63(11):1221-3. PubMed ID: 17348421
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Usefulness of extended-release topiramate in patients with epilepsy: A two-year retention study.
    Lee H; Kim DW
    J Clin Pharm Ther; 2021 Oct; 46(5):1412-1417. PubMed ID: 34146432
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.